MOEHS Group.
A world reference

In a fast growing and highly competitive market, MOEHS has managed to position itself by becoming one of the main players worldwide.

THE KEY FACTORS THAT CONFIRM THIS TRACK ARE

Consolidation of a wide range of products with different therapeutic activities: from mucolytics to ß-blockers.

Continuous expansion of our list of APIs.

Optimal balance between costs and services offered.

Ability to understand the needs transmitted by customers to transfer them to our range.

Documentary and regulatory support.

Product list

Product nameCas nºTherapeutic categoryRegulatory dataPharmacopoeiaProduction site
ACEBUTOLOL HCL34381-68-5Antianginal – Antihypertensive – AntiarrhythmicCEP, EDMF, USDMFPh. Eur. 10, USP-NF-2021, JP 16M. CANTABRA & COPRIMA
AMANTADINE HCl665-66-7Antiviral -AntiparkinsonianCEP, EDMF USDMFPh. Eur. 10 USP-NF-2021, JP 16 M. CATALANA
AMLODIPINE BESILATE111470-99-6Antianginal – AntihypertensiveCEP, EDMF, USDMF, JDMF, KDMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
ARTICAINE or CARTICAINE23964-57-0Local Anesthetic- AntiarrhythmicCEP, EDMF, USDMFPh. Eur. 10, USP-NF-2021BENECHIM
BISOPROLOL FUMARATE104344-23-2AntihypertensiveCEP, EDMF, USDMF, JDMF, NDPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
CARBOCYSTEINE638-23-3MucolyticCEP, EDMF, JDMFPh. Eur. 10, JP 16M. CATALANA & M. BCN
CARVEDILOL72956-09-3AntihypertensiveCEP, EDMF, USDMF, JDMF, KDMF, NDPh. Eur. 10, USP-NF-2021M. CATALANA & COPRIMA
CELIPROLOL HCI57470-78-7Antianginal- AntihypertensiveCEP, EDMF, JDMFPh. Eur. 10COPRIMA
CHOLINE FENOFIBRATE856676-23-8AntihyperlipidemicUSDMFIn houseCOPRIMA
DEXMEDETOMIDINE HCL145108-58-3SedativeDMFUSP-NF-2021NORCHIM & IBERICA
DULOXETINE HCL136434-34-9AntidepressantCEP, EDMF, USDMF, KDMFPh. Eur. 10, USP-NF-2021M. CANTABRA & M. BCN
FENOFIBRATE49562-28-9AntihyperlipidemicCEP, EDMF, USDMF, NDPh. Eur. 10, USP-NF-2021COPRIMA
LANSOPRAZOLE103577-45-3AntiulcerativeCEP, EDMF, USDMF, JDMF, KDMFPh. Eur. 10, USP-NF-2021M. CATALANA
LIDOCAINE HCI6108-05-0Local Anesthetic-AntiarrhythmicCEP, EDMF, USDMF, JDMFPh. Eur. 10, USP-NF-2021M. CATALANA & M. BCN
MEBEVERINE HCl2753-45-9AntispasmodicEDMF, NDPh. Eur., BP 2013BENECHIM
MEPIVACAINE HYDROCHLORIDE1722-62-9Local Anesthetic-AntiarrhythmicCEP, EDMF, USDMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
METOPROLOL TARTRATE 56392-17-7AntihypertensiveCEP, EDMF USDMF, JDMFPh. Eur. 10 USP-NF-2021, JP 16 M. CATALANA
N-ACETYLCYSTEINE616-91-1MucolyticCEP, EDMF, USDMF, NDPh. Eur. 10, USP-NF-2021M. CATALANA
NIFEDIPINE21829-25-4Antianginal-AntihypertensiveCEP, EDMF, USDMF, JDMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
NIFUROXAZIDE965-52-6AntidiarrhealEDMF, NDPh. Eur. 10COPRIMA
OLMESARTAN144689-63-4Cardiovascular angiotensin II antagonistEDMFPh. Eur. 10M. CATALANA
PANTOPRAZOLE SODIUM164579-32-2AntiulcerativeCEP, EDMF, USDMF, NDPh. Eur. 10, USP-NF-2021M. CANTABRA
PRILOCAINE BASE721-50-6Local AnestheticEDMF, USDMFPh. Eur. 9, USP-NF-2021BENECHIM
PYRANTEL EMBONATE22204-24-6AnthelminticEVMF, USVMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA & COPRIMA
QUETIAPINE FUMARATE111974-72-2AntipsychoticCEP, EDMF, USDMF, KDMFPh. Eur. 10, USP-NF-2021M. CANTABRA
RABEPRAZOLE SODIUM117976-90-6AntiulcerativeCEP, EDMF, USDMF, NDPh. Eur. 10M. CATALANA
ROPIVACAINE HCL132112-35-7Local AnestheticUSDMFPh. Eur. 10, USP-NF-2021BENECHIM
SOTALOL HCL959-24-0Antianginal-AntihypertensiveCEP, EDMF, USDMF, NDPh. Eur. 10, USP-NF-2021M. CATALANA
SUMATRIPTAN SUCCINATE103628-48-4AntimigraineEDMF, USDMF, JDMFPh. Eur. 10, USP-NF-2021M. CATALANA
TELMISARTAN144701-48-4CardiovascularEDMF, USDMF, CEPPh. Eur. 10, USP-NF-2021M. CATALANA
TRIAMTERENE396-01-0DiureticCEP, EDMF, USDMF, JDMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
TRIMEBUTINE MALEATE34140-59-5AntispasmodicCEP, EDMF, NDPh. Eur. 10, JP 16M. CATALANA & M. CANTABRA
VENLAFAXINE HCL99300-78-4AntispasmodicCEP, EDMF, USDMFPh. Eur. 10, USP-NF-2021M .CANTABRA

Products in the final phase of development

Product nameCAS N°Therapeutic categoryAvailabilityRegulatory dataPharmacopoeia
EDOXABAN (**)1229194-11-9Oral anticoagulantValidation batchesDMF
EMPAGLIFLOZIN (**)864070-44-0AntidiabeticValidation batchesDMF
LEVOBUPIVACAINE HCL (**)27262-47-1Local Anesthetic-AntiarrhythmicValidation batchesTP
REMIMAZOLAM (**)308242-62-8SedativeLaboratory batchesTP
RIVAROXABAN (**)366789-02-8Antibleeding agentValidation batchesDMFPh. Eur.
SITAGLIPTIN HCL (**)862156-92-1AntidiabeticValidation batchesDMF
SITAGLIPTIN PHOSPHATE (**)654671-77-9AntidiabeticValidation batchesDMFUSP / Ph. Eur.
VILDAGLIPTIN (**)274901-16-5AntidiabeticValidation batchesDMF

(**) Moehs is working on this compound with experimental aims, exclusively directed to obtain market authorizations of our customers’ generic medicines. We don’t intend to make any activity against any valid patent protection, as well as we will not take charge of third party actions made with the provided compound and without our knowledge against this protection.